ERIBULINA STADA
As listed in the register: ERIBULINA STADA 0,44 MG/ML SOLUCION INYECTABLE EFG
0,44 mg/ml · solución inyectable
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Eribulina
- Made by
- Laboratorio Stada S.L.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria6 matching products
- Eribulin ADVZ 0.44 mg/ml · solution for injection
- Eribulin EVER Pharma 0.44 mg/ml · solution for injection
- Eribulin STADA 0,44 mg/ml · solution for injection
- Eribulin Tillomed Eribulin Tillomed 0.44 mg/ml · solution for injection
- Eribulin Zentiva 0.44 mg/ml · solution for injection
- Sclarint 0.44 mg/ml · solution for injection
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands6 matching products
- Eribuline Baxter 0 0,44 mg/ml · oplossing voor injectie
- Eribuline EVER Pharma 0 0,44 mg/ml · oplossing voor injectie
- Eribuline Hikma 0 0,44 mg/ml · oplossing voor injectie
- Eribuline Tillomed 0 0,44 mg/ml · oplossing voor injectie
- Halaven 0 0,44 mg/ml · oplossing voor injectie
- Mevlyq 0 0,44 mg/ml · oplossing voor injectie
SwitzerlandNo exact match for this strength and form
Details
| Made by | Laboratorio Stada S.L. |
|---|---|
| Active substance | Eribulina |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 0,44 mg/ml |
| Form | solución inyectable |
| Classification | L01XX41 · Cancer treatments and immune-system medicines |
| Route | vía intravenosa |
| Marketed | Yes, according to the register |
| Generic | Yes — a generic medicine, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | ERIBULINA STADA 0,44 MG/ML SOLUCION INYECTABLE EFG |
| Nº Registro | 89127 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.